VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX)
CUSIP: 928661107
Q2 2017 13F Holders as of 30 Jun 2017
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 129,251,202
- Total 13F shares
- 4,904,719
- Share change
- +231,004
- Total reported value
- $17,350,000
- Price per share
- $3.54
- Number of holders
- 17
- Value change
- +$817,919
- Number of buys
- 5
- Number of sells
- 1
Quarterly Holders Quick Answers
What is CUSIP 928661107?
CUSIP 928661107 identifies VNRX - VOLITIONRX LTD - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 928661107:
Top shareholders of VNRX - VOLITIONRX LTD - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Lagoda Investment Management, L.P. |
13F
|
Company |
2.3%
|
2,939,079
|
$11,815,000 | — | 31 Mar 2017 | |
| Southpoint Capital Advisors LP |
13F
|
Company |
0.62%
|
800,000
|
$3,216,000 | — | 31 Mar 2017 | |
| Knoll Capital Management, LLC |
13F
|
Company |
0.36%
|
461,538
|
$1,855,000 | — | 31 Mar 2017 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.16%
|
204,994
|
$824,000 | — | 31 Mar 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.08%
|
100,890
|
$405,000 | — | 31 Mar 2017 | |
| MORGAN STANLEY |
13F
|
Company |
0.05%
|
58,900
|
$237,000 | — | 31 Mar 2017 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.02%
|
22,714
|
$91,000 | — | 31 Mar 2017 | |
| GARRISON BRADFORD & ASSOCIATES INC |
13F
|
Company |
0.01%
|
15,500
|
$62,000 | — | 31 Mar 2017 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
14,000
|
$56,000 | — | 31 Mar 2017 | |
| Creative Planning |
13F
|
Company |
0.01%
|
13,200
|
$53,000 | — | 31 Mar 2017 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.01%
|
10,962
|
$45,000 | — | 31 Mar 2017 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.01%
|
10,076
|
$41,000 | — | 31 Mar 2017 | |
| BESSEMER GROUP INC |
13F
|
Company |
0.01%
|
10,000
|
$40,000 | — | 31 Mar 2017 | |
| Advisor Group, Inc. |
13F
|
Company |
0.01%
|
7,500
|
$30,000 | — | 31 Mar 2017 | |
| UBS Group AG |
13F
|
Company |
0%
|
3,579
|
$14,000 | — | 31 Mar 2017 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
500
|
$2,000 | — | 31 Mar 2017 | |
| Intellectus Partners, LLC |
13F
|
Company |
0%
|
283
|
$1,000 | — | 31 Mar 2017 |
Institutional Holders of VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) as of Q2 2017
As of 30 Jun 2017,
VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,904,719 shares.
The largest 10 holders included
Lagoda Investment Management, L.P., Southpoint Capital Advisors LP, Knoll Capital Management, LP, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, Bank of New York Mellon Corp, NORTHERN TRUST CORP, GARRISON BRADFORD & ASSOCIATES INC, and ROYAL BANK OF CANADA.
This page lists
17
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2017 vs Q1 2017 Across Filers
Q1 2017 holders
17
Q2 2017 holders
17
Holder diff
0
| Investor | Q1 2017 Shares | Q2 2017 Shares | Share Diff | Share Chg % | Q1 2017 Value $ | Q2 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.